News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Trevejo Jose M.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Trevejo Jose M. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 1,604 shares
@ $18, valued at
$28.9k
|
|
| 10/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/23/2023 |
4
| Trevejo Jose M. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 519 shares
@ $12.89, valued at
$6.7k
Sold 529 shares
@ $12.64, valued at
$6.7k
Sold 465 shares
@ $12.15, valued at
$5.6k
|
|
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Trevejo Jose M. (Chief Medical Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Sold 499 shares
@ $13.43, valued at
$6.7k
Exercised 7,549 restricted stock units
@ $0 |
|
| 03/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/10/2023 |
4
| Trevejo Jose M. (Chief Medical Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Granted 45,459 options to buy
@ $15, valued at
$681.9k
Granted 30,792 restricted stock units
@ $0 |
|
|
|